Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Relypsa
Biotech
Vifor flies solo, plans spending spree as sister unit files IPO
Vifor Pharma has become an independent company following the IPO of its sister unit, Galenica Santé.
Nick Paul Taylor
Apr 7, 2017 2:38am
AstraZeneca’s $2.7B ZS-9 rejected again by FDA
Mar 17, 2017 7:06am
Chutes & Ladders—Germano hits the road as Intrexon restructures
Mar 16, 2017 3:43pm
AstraZeneca’s FDA delayed ZS-9 gains European thumbs-up
Feb 24, 2017 7:31am
Tricida raises $55M, to get kidney disease data this year
Jul 25, 2016 8:44am
Relypsa finally finds a buyer as Galenica coughs up $1.5B
Jul 21, 2016 7:51am
